High Expression of Both Resistin and Fascin-1 Predicts a Poor Prognosis in Patients with Colorectal Cancer

Table 2

Association of strongly positive resistin expression with clinical pathologic parameters in patients with colorectal cancer.

Variables	No.	Strongly positive resistin expression, (%)	value
Gender
Male	215	57 (26.5%)	0.609
Female	145	42 (29.0%)
Age (years)
<60	102	30 (29.4%)	0.609
≥60	258	69 (26.7%)
Tumor site
Right colon	87	27 (31.0%)	0.622
Left colon	82	20 (24.4%)
Rectum	191	52 (27.2%)
Tumor grade
High	36	12 (33.3%)	0.686
Medium	288	78 (27.1%)
Low	36	9 (25.0%)
Depth of invasion
Tis+T1/T2	61	11 (18.0%)	0.069
T3/T4	299	88 (29.4%)
Lymph node metastases
-	200	44 (22.0%)	0.009
+	160	55 (34.4%)
Tumor stage
I	42	5 (11.9%)	0.022
II	151	37 (24.5%)
III	141	49 (34.8%)
IV	26	8 (30.8%)